لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Hindi N; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital and Hospital General de Villalba, Madrid; Instituto de Investigación Sanitaria-Fundación Jimenez Díaz-UAM (IIS-FJD-UAM), Madrid, Spain. Electronic address: nhindi@atbsarc.org., Razak A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Rosenbaum E; Memorial Sloan Kettering Cancer Center, New York., Jonczak E; Department of Hematology Oncology, Miami University, Miami, USA., Hamacher R; Medical Oncology Department, West German Cancer Center, University Hospital Essen, Essen, Germany., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Bhadri VA; Medical Oncology Department, Chris O Brien Lifehouse, Sydney, Australia., Skryd A; Miller School of Medicine, University of Miami, Miami, USA., Brahmi M; Centre Leon Berard & University Claude Bernard Lyon 1, Lyon, France., Alshibany A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Jagodzinska-Mucha P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Bauer S; Medical Oncology Department, West German Cancer Center, University Hospital Essen, Essen, Germany., Connolly E; Medical Oncology Department, Chris O Brien Lifehouse, Sydney, Australia., Gelderblom H; Medical Oncology Department, Leiden University Medical Center, Leiden, The Netherlands., Boye K; Institute for Cancer Research, Oslo University Hospital, Oslo; Department of Oncology, Oslo University Hospital, Oslo, Norway., Henon C; Medical Oncology Department, Institut de Cancérologie Gustave Roussy, Villejuif, France., Bae S; Medical Oncology Department, Peter Mac Callum Center, Melbourne, Australia., Bogefors K; Department of Oncology, Skåne University Hospital and Lund University, Lund, Sweden., Vincenzi B; Medical Oncology Department, University Campus Bio-Medico, Rome, Italy., Martinez-Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza., Lopez-Martin JA; Medical Oncology Department, Hospital Universitario 12 de Octubre, Translational Oncology Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid., Redondo A; Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid., Valverde C; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona., Blay JY; Centre Leon Berard & University Claude Bernard Lyon 1, Lyon, France., Moura DS; Instituto de Investigación Sanitaria-Fundación Jimenez Díaz-UAM (IIS-FJD-UAM), Madrid, Spain., Gutierrez A; Hematology Department, Hospital Universitario Son Espases, Palma, Spain., Tap W; Memorial Sloan Kettering Cancer Center, New York., Martin-Broto J; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital and Hospital General de Villalba, Madrid; Instituto de Investigación Sanitaria-Fundación Jimenez Díaz-UAM (IIS-FJD-UAM), Madrid, Spain.

المصدر: ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102045. Date of Electronic Publication: 2023 Nov 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma, Alveolar Soft Part*/drug therapy , Sarcoma, Alveolar Soft Part*/pathology , Antineoplastic Agents*/therapeutic use, Adult ; Humans ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Middle Aged ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies ; Protein Kinase Inhibitors/therapeutic use

المؤلفون: Schmilovitz-Weiss H; Department of Gastroenterology, Rabin Medical Center, Hasharon Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Boltin D; Department of Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Groshar D; Department of Nuclear Medicine, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Domachevsky L; Department of Nuclear Medicine, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Rosenbaum E; Uro-Oncology Unit, Davidoff Cancer Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Issa N; Department of Surgery B, Rabin Medical Center, Hasharon Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Sapoznikov B; Department of Gastroenterology, Rabin Medical Center, Hasharon Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Goren I; Department of Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Issachar A; National Liver Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Cohen-Naftaly M; National Liver Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Weiss A; Geriatric Department, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Gingold-Belfer R; Department of Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel. Electronic address: rgb5895@gmail.com., Bernstine H; Department of Nuclear Medicine, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4920235, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

المصدر: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 Jun; Vol. 53 (6), pp. 753-759. Date of Electronic Publication: 2020 Dec 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3562 (Electronic) Linking ISSN: 15908658 NLM ISO Abbreviation: Dig Liver Dis Subsets: MEDLINE

مواضيع طبية MeSH: Carbon Radioisotopes* , Positron Emission Tomography Computed Tomography*, Choline/*administration & dosage , Lipotropic Agents/*administration & dosage , Liver Cirrhosis/*diagnostic imaging, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Female ; Humans ; Liver Cirrhosis/pathology ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies

المؤلفون: Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medical Center, New York, USA. Electronic address: cns9006@med.cornell.edu., Saad F; Montreal Cancer Institute, Montreal University Hospital Center (CHUM), Montreal, QC, Canada., Graff JN; Knight Cancer Institute, Oregon Health and Science University and VA Portland Health Care System, Portland, USA., Peer A; Department of Oncology, Rambam Health Care Center, Haifa, Israel., Vaishampayan UN; Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, USA., Leung E; Division of Nuclear Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada., Rosenbaum E; Institute of Oncology, Rabin Medical Center-Davidoff Cancer Center, Petah Tikva, Israel., Gurney H; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia., Epstein RJ; Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia., Davis ID; Department of Medicine, Monash University, Melbourne, Australia; Eastern Health, Melbourne, Australia., Wu B; Clinical Statistics Oncology, Bayer HealthCare Pharmaceutical Inc, Whippany, USA., Trandafir L; Global Clinical Development, Bayer Consumer Care AG, Basel, Switzerland., Wagner VJ; Global Clinical Development, Bayer Consumer Care AG, Basel, Switzerland., Hussain M; Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Feb; Vol. 31 (2), pp. 257-265. Date of Electronic Publication: 2019 Dec 23.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Bone Neoplasms*/drug therapy , Bone Neoplasms*/radiotherapy , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/radiotherapy , Radium*/adverse effects, Humans ; Male ; Radioisotopes

المؤلفون: Tolwin Y; Shaare Zedek Medical Center, Jerusalem, Israel., Gillis R; The Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva, Israel; Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Agmon IN; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Davidoff Cancer Center, Rabin Medical Center, Petach Tiqwa, Israel., Shrem NS; The Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva, Israel; Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Rosenbaum E; Davidoff Cancer Center, Rabin Medical Center, Petach Tiqwa, Israel., Peled N; The Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva, Israel; Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. Electronic address: peled.nir@gmail.com.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2019 Nov; Vol. 20 (6), pp. 429-434. Date of Electronic Publication: 2019 Jun 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell/*diagnosis , Lung/*diagnostic imaging , Lung Neoplasms/*diagnosis , Neoplasms, Multiple Primary/*epidemiology , Urinary Bladder Neoplasms/*diagnosis, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Transitional Cell/epidemiology ; Child ; Child, Preschool ; Cohort Studies ; Early Detection of Cancer ; Female ; Humans ; Incidence ; Infant ; Infant, Newborn ; Israel/epidemiology ; Lung Neoplasms/epidemiology ; Male ; Middle Aged ; Risk ; Sex Factors ; Smoking/adverse effects ; Urinary Bladder Neoplasms/epidemiology ; Young Adult

المؤلفون: Sartor O; Departments of Medicine and Urology, Tulane Cancer Center, New Orleans, USA;. Electronic address: osartor@tulane.edu., Heinrich D; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Mariados N; Department of Radiation Oncology, Associated Medical Professionals of New York, PLLC, Syracuse, USA., Méndez Vidal MJ; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofia Hospital, University of Cordoba, Cordoba, Spain., Keizman D; Genitourinary Oncology Service, Meir Medical Center, Kfar Saba, Israel., Thellenberg Karlsson C; Department of Radiation Sciences, Cancer Center Norrlands University, Umeå, Sweden., Peer A; Division of Oncology, Rambam Health Care Campus, Haifa, Israel., Procopio G; Fondazione Istituto Nazionale Tumori Oncologia Medica Genitourinaria, Milan, Italy., Frank SJ; Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel., Pulkkanen K; Department of Oncology, Kuopio University Hospital, Kuopio, Finland., Rosenbaum E; Uro-Oncology Unit, Rabin Medical Center-Davidoff Center, Petah Tikva, Israel., Severi S; Romagnolo Scientific Institute for the Study and Care of Cancer-IRST IRCCS, Nuclear Medicine Therapeutic Unit, Meldola, Italy., Trigo Perez JM; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Wagner V; Global Clinical Development, Bayer Pharma AG, Basel, Switzerland., Li R; Global Research and Development Statistics, Bayer HealthCare Pharmaceuticals, Whippany., Nordquist LT; Department of Medical Oncology, GU Research Network, LLC, Omaha, USA.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Oct 01; Vol. 28 (10), pp. 2464-2471.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Bone Neoplasms/*radiotherapy , Bone Neoplasms/*secondary , Prostatic Neoplasms, Castration-Resistant/*radiotherapy , Radium/*administration & dosage, Aged ; Aged, 80 and over ; Alkaline Phosphatase/metabolism ; Bone Neoplasms/diagnostic imaging ; Bone Neoplasms/metabolism ; Humans ; Kallikreins/metabolism ; Male ; Middle Aged ; Prospective Studies ; Prostate-Specific Antigen/metabolism ; Prostatic Neoplasms, Castration-Resistant/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology ; Radium/adverse effects ; Re-Irradiation